Who Attends

The following represents a selection of companies who have attended or are confirmed to attend upcoming editions. In line with data protection regulations, we do not disclose individual delegate information. You can explore a range of C-suite testimonials through the link below or contact us for further details.

Join the circle

Who Attends

Qualifies Invitation

NORTHERN EUROPE

Focus: AI integration, translational medicine, advanced manufacturing and clinical innovation.

* AstraZeneca (UK/Sweden)

* GSK (UK)

* Novo Nordisk (Denmark)

* Lundbeck (Denmark)

* Genmab (Denmark/Netherlands)

* Orchard Therapeutics (UK)

* Autolus Therapeutics (UK)

* Oxford Biomedica (UK)

* ReNeuron (UK)

* Immunocore (UK)

* Adaptimmune (UK)

* eTheRNA Immunotherapies (Belgium)

* uniQure (Netherlands)

* Galapagos NV (Belgium/Netherlands)

* Aqemia (France — AI drug discovery)

* Exscientia (UK)

* BenevolentAI (UK)

* BioNTech SE (Germany)

* Evotec SE (Germany)

Welcomed Invites

Chief Scientific Officer, VP Cell Therapy, Head of CMC, Director Bioprocess Development, VP AI R&D, Chief Data Officer, Head of Gene Therapy, VP Manufacturing Strategy.

SOUTHERN EUROPE / GLOBAL SOUTH

Focus: translational innovation, AI adoption, clinical and regulatory harmonisation, and manufacturing readiness.

* Chiesi Farmaceutici (Italy)

* Grifols (Spain)

* PharmaMar (Spain)

* Minaris Regenerative Medicine (Japan / EU base in Munich)

* Fujifilm Diosynth Biotechnologies (Japan / UK / Denmark ops)

* Takeda Pharmaceuticals (Japan HQ / Europe hub in Zurich)

* Astellas Pharma (Japan)

* Kyorin Pharma (Japan)

* Samsung Biologics (South Korea)

* KBI Biopharma (US HQ / Geneva EU hub)

* Lonza Group (Switzerland)

* WuXi AppTec / WuXi Biologics (China HQ / EU ops)

* Tigen Pharma (Switzerland)

* MedinCell (France)

* Anemocyte (Italy)

* CART Therapy Center (Spain)

Welcomed Invites

 VP Cell Manufacturing, Head of Process Development, Global Head of Regulatory Affairs, Senior Director Clinical Operations, VP Partnerships, Director Innovation Strategy.

DAX / CENTRAL EUROPE / MULTINATIONALS

Focus: global manufacturing networks, strategic investments, advanced therapies and automation.

* Roche (Switzerland)

* Novartis (Switzerland)

* Bayer AG (Germany)

* Merck KGaA (Germany)

* Sanofi (France)

* Boehringer Ingelheim (Germany)

* CureVac (Germany)

* MorphoSys AG (Germany)

* BioM Biotech Cluster Development (Germany)

* CeGaT GmbH (Germany)

* Replimune (UK/Germany ops)

* Polpharma Biologics (Poland)

* Sartorius Stedim Biotech (Germany/France)

* Miltenyi Biotec (Germany)

* Thermo Fisher Scientific (global, DACH leadership in bioservices)

Welcomed Invites

Head of Biotech Innovation, VP Cell & Gene Therapy Manufacturing, Global Head Digital Strategy, Chief Translational Officer, VP External Innovation, Head of Partnerships Europe.